Universal Health Services (UHS) Adds A $700 Million Loan, Is The Stock Still Cheap?
Why Universal Health Services stock is in focus
Universal Health Services (UHS) is back on investors radar after two recent corporate moves: a new delayed draw term loan facility of up to $700 million and a reaffirmed quarterly cash dividend.
See our latest analysis for Universal Health Services.
At a share price of $149.91, Universal Health Services has seen its 7 day share price return rise 3.94% and its 30 day share price return rise 6.19%. However, the 90 day share price return has fallen 17.05%, the year to date share price return is down 31.82%, and the 1 year total shareholder return has declined 7.46%, pointing to pressure on long term sentiment even as the recent debt facility and dividend decision keep the stock in focus.
If this kind of healthcare story has your attention, it can be helpful to see what else is moving in the sector by checking out 39 healthcare AI stocks
Universal Health Services now trades well below both analyst targets and one estimate of intrinsic value. The real tension is whether this recent loan and dividend clarity point to a discount that still makes sense.
Most Popular Narrative: 29.9% Undervalued
The most followed narrative on Universal Health Services currently points to a fair value of $213.82 versus the last close of $149.91, putting the focus squarely on whether that valuation gap is justified.
The company's aggressive buildout of outpatient behavioral health facilities positions it to capture a greater share of rising demand for mental and behavioral health services, a trend driven by increased societal awareness and destigmatization, which is expected to support long-term revenue and EBITDA growth as the mix shifts toward higher-margin, lower-cost care settings.
Curious what earnings profile, revenue path, and margin reset are baked into that fair value for Universal Health Services? The narrative relies on specific growth, profitability, and valuation multiple assumptions that together present a very different picture from the current share price.
Result: Fair Value of $213.82 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, investors still need to watch for any meaningful cuts to Medicaid supplemental payments or persistent labor shortages, as either could pressure Universal Health Services margins and growth assumptions.
Find out about the key risks to this Universal Health Services narrative.
Next Steps
Given the mix of pressure and potential around Universal Health Services, it makes sense to move quickly and review the underlying data yourself, starting with the 3 key rewards and 2 important warning signs
Looking for more investment ideas beyond Universal Health Services?
Do not stop with Universal Health Services. Broaden your watchlist with a few focused stock ideas that match clear goals and stronger, more disciplined investing habits.
- Target income potential with companies that pay out consistently by reviewing the 9 dividend fortresses and seeing which yields stand out for you.
- Hunt for shares that trade below what their fundamentals might justify by scanning the 50 high quality undervalued stocks and comparing them with your existing holdings.
- Prioritise resilience by filtering for companies with stronger financial footing using the solid balance sheet and fundamentals stocks screener (48 results) to stress test your next idea before committing capital.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com